MUMBAI / NEW DELHI, SEPTEMBER 16, 2026 — During trading on Wednesday, primary market participants turned their focus toward the upcoming initial public offering of Himalaya Nutravedics, which has officially scheduled its book-built SME issue to open on September 22, 2026. According to regulatory filings tracked across IPOWatch and Chittorgarh, the company is set to mobilize ₹26.50 crores through a fresh issue of equity shares, with a price band fixed at ₹100 to ₹106 per equity share of face value ₹10.
Himalaya Nutravedics IPO
NSE: BSE
▼ ₹50.80 (-1.53%)
Day Range: ₹3,237.90 – ₹3,317.00
52W Range: ₹2,021.50 – ₹4,446.80
● Real-Time Feed
Himalaya Nutravedics IPO: Key Dates & Milestone Timeline
Investors tracking the Himalaya Nutravedics SME issue must note the strict chronological milestones mandated by exchange filings and registrar schedules. The bidding window spans three sessions, concluding on September 24, 2026.
| Event / Catalyst Milestone | Exact Calendar Date |
|---|---|
| IPO Open Date | September 22, 2026 |
| IPO Close Date | September 24, 2026 |
| Basis of Allotment Finalisation | September 25, 2026 |
| Initiation of Refunds / Demat Credit | September 28, 2026 |
| BSE SME Listing Date | September 29, 2026 |
Key Issue Details & Financial Parameters
Data collated from primary market intelligence platforms outlines the structural breakdown of the Himalaya Nutravedics public offering.
| Financial Metric / Parameter | Details |
|---|---|
| Price Band | ₹100 to ₹106 per share |
| Total Issue Size | ₹26.50 Crores |
| Fresh Issue Component | ₹26.50 Crores |
| Face Value | ₹10 per share |
| Minimum Market Lot Size | 1,200 Shares |
| Retail Quota (RII) | 35% |
| Qualified Institutional Buyers (QIB) | 50% |
| High Net Worth Individuals (HNI) | 15% |
| Listing Exchange | BSE SME Platform |
Grey Market Premium (GMP) Tracking
As of Wednesday, September 16, 2026, grey market tracking reports compiled by IPOWatch and Chittorgarh indicate early unverified street momentum. Investors are advised to monitor grey market premium trends closer to the September 22 opening date for shifts in unstructured speculative demand.
Financial Performance & Fundamental Review
According to fundamental financial reports extracted from company filings, Himalaya Nutravedics has demonstrated robust top-line expansion and profitability growth:
- Fiscal Year 2026: Reported revenue stood at ₹43.12 crores, compared to ₹21.00 crores in fiscal year 2025.
- Net Profit Growth: Net profit surged to ₹7.39 crores for 2026, marking a substantial increase against ₹2.23 crores recorded in 2025.
Brokerage research and primary market reviews suggest that the strong scaling of revenues and bottom-line margins makes the offering worth evaluating for long-term investors willing to shoulder SME segment liquidity risks.
Peer Comparison & Sector Benchmarks
Evaluating valuation multiples against listed nutraceutical and specialty manufacturing peers helps contextualize the asking price band.
| Company / Peer Name | P/E Ratio | Market Cap / Issue Size | Key Note |
|---|---|---|---|
| Himalaya Nutravedics (This IPO) | Pending RHP | ₹26.50 Cr | Fresh issue scaling rapidly. |
| Peer comparison data sourced from Screener.in and Trendlyne | – | – | Detailed peer multiples update upon final RHP filing. |
Peer valuation data sourced from Screener.in and Trendlyne
Bull vs. Bear Catalysts
Growth Catalysts (Bull Case)
- Rapid top-line scaling, with revenues doubling from ₹21.00 crore in 2025 to ₹43.12 crore in 2026.
- Significant net profit expansion from ₹2.23 crore to ₹7.39 crore over the same period.
- Dedicated focus on nutraceuticals addressing growing health and wellness consumption trends.
Key Downside Risks (Bear Case)
- SME segment liquidity constraints can lead to wide bid-ask spreads post-listing.
- Execution risks associated with deploying ₹26.50 crore fresh issue capital efficiently.
Investment Verdict
Suitable For: Long-term investors comfortable with SME equity risk
Risk Level: High — inherent volatility of SME platform listings and micro-cap scaling
Key Watch Point: Subscription velocity across QIB and HNI quotas during September 22–24 bidding
Investor Frequently Asked Questions (FAQ)
When does the Himalaya Nutravedics IPO open and close?
The IPO opens for subscription on September 22, 2026, and closes on September 24, 2026.
What is the price band and minimum investment for the IPO?
The price band is fixed at ₹100 to ₹106 per share with a minimum market lot size of 1,200 shares.
Where will Himalaya Nutravedics shares be listed?
The shares are scheduled to be listed on the BSE SME platform on September 29, 2026.
SEBI Compliance & Statutory Disclaimer
The information and analysis presented on IPO Bulletin (ipobulletin.com) are for informational and educational purposes only and do not constitute financial, investment, or legal advice. Securities market investments are subject to market risks; please read all offer documents (DRHP/RHP) thoroughly before committing capital. Grey Market Premium (GMP) figures are unofficial, unregulated street estimates. Always consult a SEBI-registered investment advisor before making financial decisions.
Sources cross-checked for this article: IPOWatch, Chittorgarh, Screener.in, BSE India filings.